In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type 1 selected

Type

Guidance programme 1 selected

Guidance programme

Showing 1 to 3 of 3

TitleConsultationTypeConsultation end date
Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer [ID6339]Draft guidanceTechnology appraisal guidance
Dupilumab for treating moderate to severe chronic obstructive pulmonary disease ID6235Draft guidanceTechnology appraisal guidance
Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive, HER2-negative early breast cancer [ID6153]Draft guidanceTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All